exenatide once weekly
Sponsors
AstraZeneca
Conditions
Children and Adolescent With Type 2 DiabetesType 2 DiabetesType 2 Diabetes Mellitus
Phase 1
A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
CompletedNCT00612794
Start: 2007-09-30End: 2008-05-31Updated: 2015-02-24
A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
CompletedNCT00894322
Start: 2009-04-30End: 2009-08-31Updated: 2015-09-18
Phase 2
Phase 3
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
CompletedNCT00637273
Start: 2008-01-31End: 2009-07-31Updated: 2015-04-07
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
CompletedNCT00641056
Start: 2008-04-30End: 2009-11-30Updated: 2015-06-15
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
CompletedNCT00676338
Start: 2008-11-30End: 2011-01-31Updated: 2015-04-09
A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
CompletedNCT00877890
Start: 2009-03-31End: 2010-01-31Updated: 2015-04-07
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
CompletedNCT00917267
Start: 2009-07-31End: 2011-04-30Updated: 2015-04-09
Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus
CompletedNCT00935532
Start: 2009-07-31End: 2011-07-31Updated: 2015-06-15
Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
CompletedNCT01003184
Start: 2009-10-31End: 2011-12-31Updated: 2015-04-07
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
CompletedNCT01029886
Start: 2010-01-31End: 2011-04-30Updated: 2015-04-09
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
CompletedNCT01144338
Start: 2010-06-18End: 2017-04-24Updated: 2018-08-08
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
CompletedNCT01554618
Start: 2011-12-02End: 2021-05-05Updated: 2021-11-30
Unknown Phase
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
CompletedNCT02917057
Start: 2015-08-01End: 2015-08-01Updated: 2018-03-29
Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
CompletedNCT02974244
Start: 2014-10-28End: 2014-10-28Updated: 2017-03-29
Clinical Outcomes of Exenatide Versus Basal Insulin
CompletedNCT02987348
Start: 2015-06-30End: 2015-06-30Updated: 2017-03-29
Related Papers
20 more papers not shown